Effectivity of interventions to prevent mental illness at the workplace
Not Applicable
- Conditions
- psychosomatic illness at the workplaceF32Depressive episode
- Registration Number
- DRKS00011371
- Lead Sponsor
- niklinikum für Psychosomatische Medizin und Psychotherapie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 126
Inclusion Criteria
Group 1: Participation in a manager training concerning mental health in the survey period
Group 2: Attendance at the psychosomatic consultation-hour in the survey period
Group 3: Involvement in the implementation process of the inter-ventions
Group 4: employees of the company
Exclusion Criteria
participants of firms not included in the agreement
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Data will be collected at three different measurement dates T1 (di-rectly before/after the intervention), T2 (3 months follow-up) und T3 (12 months follow-up).<br>Group 1 (T1 & T3): Changes in the participant’s knowledge and atti-tudes concerning mental illness via questionnaire (MAKS, Soziale Distanzskala, Einzelitems) and personal experiences with the imple-mentation process (qualitative interview)<br>Gruppe 2 (T1, T2 & T3): Identification of changes since the consulta-tion hour (concerning the illness’ severity, life quality and work abil-ity) - via questionnaire (WAI, PHQ, SF-12, MABI, IS) and personal experiences with the implementation process (qualitative inter-view).<br>Group 3 (T3): personal experiences with the implementation process (qualitative interview)<br>
- Secondary Outcome Measures
Name Time Method Additionally collected data:<br>Group 1 (T1 & T3): Changes of the participant‘s job situation, work-load and the health situation. Via questionnaires (ERI, SF-12, PHQ-9, IS).<br>Group 2 (T1, T2 & T3): patient satisfaction and changes in the partici-pant’s attitudes concerning mental illness. Via questionnaires (ZUF-8).<br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie workplace interventions in preventing depressive episodes (F32)?
How effective are psychosomatic workplace interventions compared to standard mental health care protocols?
Are there specific biomarkers associated with response to mental health workplace prevention strategies?
What adverse events are reported in workplace mental health intervention trials and how are they managed?
What combination approaches or competitor drugs exist for workplace prevention of psychosomatic illness?